NorthWest Biotherapeutics Inc (NWBO)

[Extremist223]

FDA required the company to establish efficacy with a monotherapy, despite the science indicating that combination should be more effective. - Linda Powers 2022 ASM

FDA required the crossover portion of the trial. - Steven Toms Surgeon MD (DCVax-L® Press Conference at Rhode Island Lifespan Cancer Institute)

I can understand requiring crossover because of ethical reasons + leukapheresis is invasive + they can measure efficacy with new tools, but forcing someone to establish efficacy in a monotherapy when they know the mechanism that inactivates t-cells is strange behaviour.

Liau did a paper on Tgf-b in 1998
https://drive.google.com/file/d/1wU1mNr4Sx13softCikfJW0L5B0MSO-9T/view?usp=share_link

Looks like the FDA did those AMERICAN market makers a favour. Still bullish on this stock, but market making should no longer exist after our lawsuit is through. Back to selling only shares you have. No fail to deliver, no providing liquidity. All that is, is digging your grave over the life of the stock.

The Americans absolutely would allow you to buy, buy, buy like Jim Cramer and then at the end when you set the price during a buyout, they will begin to describe how they also sold 1000x as many shares to their friend, and even though they failed to deliver those shares, they are still financial obligations. So Ken Griffin/Market Makers/AMERICA can't pay you in full because he owes his best friend Sus-que-Hanna. I hope that Klixen for you.

That's where we discover that he didn't maintain his mandate of equal purchases and sales, not because China bought the whole time, but because Ken also sold even more shares to his friends pushing himself even further away from net neutral, and even deeper into his own grave. To that I say Great Gaming Linda Powers.

Suing instead of a buyout might be a better approach.